Recent advances in Circulating Nucleic Acids in oncology.

07:00 EST 7th February 2019 | BioPortfolio

Summary of "Recent advances in Circulating Nucleic Acids in oncology."

Circulating cell-free DNA (cfDNA) is one of the fastest growing and most exciting areas in oncology in recent years. Its potential clinical uses cover now each phase of cancer patient management care (predictive information, detection of the minimal residual disease, early detection of resistance, treatment monitoring, recurrence surveillance, and cancer early detection/screening). This review relates the recent advances in the application of circulating DNA or RNA in oncology building on unpublished or initial findings/work presented at the 10th international symposium on circulating nucleic acids in plasma and serum (CNAPS) held in Montpellier from the 20th to the 22nd of September 2017. This year, presenters revealed their latest data and crucial observations notably in relation to (i), the circulating cell free (cfDNA) structure and implications regarding their optimal detection; (ii), their role in the metastatic or immunological processes; (iii), evaluation of miRNA panels for cancer patient follow up; (iv), the detection of the minimal residual disease; (v), the evaluation of a screening tests for cancer using cfDNA analysis; and (vi), elements of pre-analytical guidelines. This work reviews the recent progresses in the field brought to light in the meeting, as well as in the most important reports from the literature, past and present. It proposes a broader picture of the basic research and its potential, and of the implementation and current challenges in the use of circulating nucleic acids in oncology.


Journal Details

This article was published in the following journal.

Name: Annals of oncology : official journal of the European Society for Medical Oncology
ISSN: 1569-8041


DeepDyve research library

PubMed Articles [16261 Associated PubMed Articles listed on BioPortfolio]

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.

In advanced prostate cancer (PC), there is increasing investigation of circulating biomarkers, including quantitation and characterization of circulating tumour cells and cell-free nucleic acids, for ...

Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.

Blood of pregnant women contains cell-free fetal DNA (cffDNA), which is widely used in non-invasive prenatal diagnosis. The modern laboratory equipment market provides huge variety of commercial kits ...

Nucleic Acid-Based Therapeutics for Pulmonary Diseases.

Nucleic acid-based therapeutics present huge potential in the treatment of pulmonary diseases ranging from lung cancer to asthma and chronic pulmonary diseases, which are often fatal and widely preval...

Functional assays for transcription mechanisms in high-throughput.

Dramatic increases in the scale of programmed synthesis of nucleic acid libraries coupled with deep sequencing have powered advances in understanding nucleic acid and protein biology. Biological syste...

Challenges and current status of computational methods for docking small molecules to nucleic acids.

Since the development of the first docking program in 1982, the use of docking-based in silico screening for potentially bioactive molecule discovery has become a common strategy in academia and pharm...

Clinical Trials [3901 Associated Clinical Trials listed on BioPortfolio]

The STRIVE Study: Breast Cancer Screening Cohort

GRAIL is using high-intensity sequencing of circulating cell-free nucleic acids (cfNAs) to develop blood tests to detect cancer early. The purpose of this study is to train and validate an...

Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel

The FilmArray Meningitis/Encephalitis (ME) Panel (hereinafter referred to as FilmArray ME Panel) is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use w...

Omega 3 Fatty Acids and Systemic Lupus Erythematosus

Omega-3 fatty acids have been considered anti-inflammatory lipids based on data from epidemiological studies of Greenland Eskimos whose diet is rich in fish, sources of polyunsaturated fat...

Trends in Modern Phase 1 Oncology Trials

Overview of response rate published in recent oncology phase I trials

Assay Development for Cancer Biomarkers

Tumour biomarkers are substances produced by cancer or by other cells of the body in response to cancer conditions. They are used to help detect, diagnose, manage and predict outcome or re...

Medical and Biotech [MESH] Definitions

Nucleic acids (DNA or RNA) found circulating in SERUM; PLASMA; or other BODY FLUIDS.

Obtaining material for pathological examination and analysis, from bodily fluids. Material retrieved includes CELL-FREE NUCLEIC ACIDS; CELL-DERIVED MICROPARTICLES; EXOSOMES; CIRCULATING NEOPLASM CELLS; and other circulating cells and CELLULAR STRUCTURES.

Educational programs designed to inform nurses of recent advances in their fields.

Educational programs designed to inform physicians of recent advances in their field.

Educational programs designed to inform dentists of recent advances in their fields.

Quick Search


DeepDyve research library

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Searches Linking to this Article